ArticleAging medicine (Milton (N.S.W))2025
A Phase 3 Multicenter, Double-Blind Study Comparing Efficacy, Safety, Immunogenicity, and Pharmacokinetics of Alkem's Biosimilar Teriparatide Versus Reference Teriparatide in Postmenopausal Osteoporosis.
Nitin Kapoor et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.